Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New ultrasound test may improve how we give lifesaving lung medicine to preemies

NCT ID NCT07514481

First seen Apr 19, 2026 · Last updated May 20, 2026 · Updated 4 times

Summary

This study looks at two methods of giving surfactant, a medicine that helps premature babies breathe, to see which one spreads the medicine more evenly in the lungs. About 22 preterm infants with respiratory distress syndrome will receive surfactant either through a thin tube placed in the windpipe (LISA method) or through a breathing tube (conventional method). Doctors will use lung ultrasound to measure how well the medicine spreads, aiming to find the best way to deliver this treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY DISTRESS SYNDROME, NEWBORN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Women's Wellness and Research Center (WWRC), Hamad Medical Corporation

    RECRUITING

    Doha, Qatar

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.